Ling Yang

Ling Yang currently works at Hangzhou Adicon Clinical Laboratories, Inc., as Chairman from 2018, ADICON Holdings Ltd., as Non-Executive Chairman from 2018, HUTCHMED (China) Ltd., as Non-Executive Director from 2023, Ambio Pharmaceuticals, as Non-Executive Director from 2021, Ambio, Inc., as Director, Carlyle Asia Investment Advisors Ltd., as Managing Director from 2011, and The Phi Beta Kappa Society, as Member.
Ms. Yang also formerly worked at Shenzhen Salubris Pharmaceuticals Co., Ltd., as Director, Ambio Holdings, Inc., as Director, The Carlyle Group Inc., as Vice President & Managing Director, KKR Asia Ltd., as Principal from 2008 to 2011, The Carlyle Group Inc., as Associate from 2005 to 2006, and Kohlberg Kravis Roberts & Co.(Beijing), as Principal from 2008 to 2011.
Ms. Yang received her undergraduate degree in 2002 from Smith College and Masters Business Admin degree in 2008 from Harvard Business School.